Friday, August 26, 2016 9:57:09 AM
I brought some IVFH in the 40's (.43-.44) here is what I like.
1) IVFH is a revenue growth story with solid 15% revenue growth through 6 months ended, so we are seeing solid top line growth.
2) IVFH had NI of 575k for three months ending, and 956k for 6 months ending respectively. I wouldn't use their adjusted eps numbers but I would add back the almost 132k for amortization. Hence q1 adjusted by my count is .014 in q1 and .02 in q2 for a total of .034, and I expect Number to improve from q2 levels in q3 and q4. I expect earnings to be around .05 combined the next two quarters (adjusted adding back just amortization), Hence the company will be on a .10 annualized basis based on my estimates of where the second half eps will be if I'm correct, hence trading at a PE of 4 going foward if my estimates are correct, even right now we are at about 5 times q2 annualized.
3) Stock is waaaaaaaaaaaaaaaaaaay off its highs which for me is always a plus to buy things that have not really gone up yet.
The primary thing that worry me here as every stock has its warts. 1) High customer concentration as they are heavily dependent on US foods, so that is why I plan to keep the position super tiny, but I can't see any reason why the stock shouldn't at least trade at a pe of 7-8 so even right now I would say it is worth at least .60 and I'm being overly conservative with these estimates, I could see a case where this easily doubles in 6-12 months if all goes well. Of course the high customer concentration is the thing that can come back and bite them, but I think the Risk/Reward is attractive at current levels. All is just my opinion, and I could always be wrong though.
---All above is just my humble opinion.
And I could always be wrong.
And as always do your own DD.---
http://www.investorshub.com/boards/board.asp?board_id=5316
Recent IVFH News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:10:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:57:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 10:09:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 10:23:41 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/09/2024 07:19:49 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 11:38:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:17:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:23:04 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 09:24:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 10:10:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:01:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 04:55:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/16/2023 12:35:25 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:31:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 04:01:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2023 09:01:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2023 10:36:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 09:27:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 09:09:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 08:59:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 03:01:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2023 08:22:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2023 08:03:28 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM